What is the current Transmembrane Protein market size?

The Transmembrane Protein market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Transmembrane Protein market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Transmembrane Protein market?

Key drivers include rising research and development activities and growing applications in pharmaceuticals.

What are the major challenges facing the Transmembrane Protein market?

Challenges include high development costs and complex regulatory requirements.

Which regions are expected to lead the Transmembrane Protein market?

North America and Europe are expected to dominate the market due to strong research infrastructure.

Who are the top companies in the Transmembrane Protein market?

Top companies include Pfizer, Merck, and Johnson & Johnson, driving innovation and growth.

What future opportunities exist in the Transmembrane Protein market?

Future opportunities include emerging applications in biotechnology and personalized medicine.

How will technology impact the Transmembrane Protein market future outlook?

Advances in gene editing and biotechnology will drive growth and innovation in the market.

What is the current regulatory landscape for the Transmembrane Protein market?

The regulatory landscape is complex, with strict guidelines and approvals required for new products.

Transmembrane Protein Expansion Opportunities & Forecast Analysis 2033

Transmembrane Protein by Application (Cell Experiment, Immunoassay, CAR Positive Test), by Types (Tetraspanin, Pentaspanin, Seven Transmembrane Proteins, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Transmembrane Protein Market Size | CAGR 10.5 Forecast 2033

Transmembrane Protein Expansion Opportunities & Forecast Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Transmembrane Protein Market Overview

The Transmembrane Protein market refers to the global industry involved in the research, development, and application of transmembrane proteins, which are crucial for various cellular processes. As the Transmembrane Protein market size is estimated to be around $1.4 billion, the growth outlook is promising, with a projected market forecast of $2.5 billion by 2033, driven by the increasing demand for novel therapeutics and diagnostics. The industry expansion is expected to be driven by advances in technology, rising investments in research and development, and growing applications in the pharmaceutical and biotechnology sectors. The scope of the market encompasses various types of transmembrane proteins, including G-protein coupled receptors, ion channels, and transporters, with applications in drug discovery, diagnostics, and basic research.

Loading chart…

The Transmembrane Protein market is expected to grow at a CAGR of 8-10% during the forecast period, driven by the increasing demand for novel therapeutics and diagnostics. Key forces shaping the industry include technology shifts, such as advances in gene editing and gene therapy, regulations, such as those related to drug development and approval, and consumer behavior, such as the growing demand for personalized medicine. The largest region in the Transmembrane Protein market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing investments in research and development and the growing demand for novel therapeutics and diagnostics. The market is expected to be driven by the growing applications in the pharmaceutical and biotechnology sectors, with major players focusing on the development of novel therapeutics and diagnostics targeting transmembrane proteins.

Report Overview

Report Attribute	Details
Market size value in 2025	1.50 billion
Revenue forecast in 2033	3.33 billion
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ACROBiosystems; Dima Biotech; Abiocenter; Sino Biological; Detai Bioengineering; Kactus Biosystems; Cusabio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Transmembrane Protein market is poised for significant growth, driven by factors that are reshaping the industry landscape. Understanding the dynamics at play is crucial for strategy leaders and business development heads seeking to capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in genomic sequencing and proteomics technologies are enabling the discovery of novel transmembrane proteins, thereby expanding the Transmembrane Protein market size and its growth forecast.

Increasing demand for targeted therapies, particularly in oncology and infectious diseases, is driving the adoption of transmembrane proteins as potential drug targets, fueling the growth of the Transmembrane Protein market.

Restraints2 items

High development costs and the complexity of structure-based drug design for transmembrane proteins are significant barriers to entry, potentially limiting the Transmembrane Protein market size and hindering its growth forecast.

Stringent regulatory requirements and the need for extensive preclinical and clinical trials can delay the approval and commercialization of transmembrane protein-based therapeutics, impacting the Transmembrane Protein market growth.

Opportunities2 items

The emerging precision medicine paradigm presents opportunities for targeted transmembrane protein therapies, potentially expanding the Transmembrane Protein market size and enhancing its growth forecast.

Collaborations between academic institutions, biotechnology firms, and pharmaceutical companies can facilitate the translation of transmembrane protein research into clinical applications, driving growth in the Transmembrane Protein market.

Challenges2 items

The intellectual property landscape for transmembrane proteins can be complex, with potential patent disputes and licensing challenges that may hinder the growth of the Transmembrane Protein market and its growth forecast.

Ensuring the scalability and cost-effectiveness of transmembrane protein production processes is crucial for commercial viability, as high costs could limit the Transmembrane Protein market size and impact its growth.

Market Segmentation

Loading chart…

The Application segment of the Transmembrane Protein market is a crucial aspect of Transmembrane Protein segmentation. This market can be divided into various application-based categories, including therapeutic and diagnostic applications. Therapeutic applications involve the use of transmembrane proteins in drug development, while diagnostic applications utilize these proteins in disease diagnosis and monitoring. Each application contributes significantly to the overall Transmembrane Protein market size, with the therapeutic segment being the largest contributor due to the increasing demand for targeted therapies.

The Types segment of the Transmembrane Protein market is another essential aspect of market taxonomy. This segment can be further divided into subtypes such as alpha-helical and beta-barrel transmembrane proteins. Alpha-helical transmembrane proteins are the most common type and play a critical role in various cellular processes, including cell signaling and transport. Beta-barrel transmembrane proteins, on the other hand, are primarily found in the outer membrane of gram-negative bacteria and are involved in functions such as pore formation and transport. Understanding these subtypes is crucial for the development of effective therapies and diagnostics, ultimately contributing to the growth of the Transmembrane Protein market.

Transmembrane Protein Segmentation Breakdown9 items

Application

Cell Experiment

Immunoassay

CAR Positive Test

Types

Tetraspanin

Pentaspanin

Seven Transmembrane Proteins

Others

Regional Insights

Loading chart…

The Transmembrane Protein market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced technologies, favorable policies, and significant investments in research and development.

Key drivers for North America include a mature ecosystem, high infrastructure investment, and a large patient population. In Europe, drivers include a strong regulatory framework, increasing demographics with unmet medical needs, and growing investment in life sciences research. Asia Pacific's growth is driven by expanding infrastructure, rising adoption of innovative therapies, and government policies supporting the biotechnology sector.

Latin America's Transmembrane Protein market growth is expected to be driven by improving infrastructure, growing investment in healthcare, and increasing adoption of advanced medical technologies. The Middle East & Africa region is anticipated to experience growth due to rising demographics, expanding infrastructure, and increasing investment in the healthcare sector, contributing to the overall regional forecast.

Competitive Landscape

The Transmembrane Protein market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Transmembrane Protein competitive landscape is driven by key competitive levers including certifications, regulatory approvals, and strategic partnerships. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are leveraging their regional presence and cost advantages to compete.

Companies in the Transmembrane Protein market are adopting various strategies to differentiate themselves, including investing in research and development, expanding their sales channels, and offering customized services. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies need to focus on innovation, quality, and customer service. The following companies are examples of key players in the market:

ACROBiosystems: regional expansion

Dima Biotech: innovation pipeline

Abiocenter: premium pricing

Sino Biological: OEM tie-ups

Detai Bioengineering: local manufacturing

Kactus Biosystems: vertical integration

Key Transmembrane Protein Companies7 items

ACROBiosystems

Dima Biotech

Abiocenter

Sino Biological

Detai Bioengineering

Kactus Biosystems

Cusabio

Market Ecosystem

The Transmembrane Protein ecosystem encompasses a complex network of stakeholders, spanning upstream, midstream, and downstream activities. It involves technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. The ecosystem's boundaries are defined by the interactions among these participants, from raw material sourcing to end-user applications, with each stage influencing the overall value chain analysis.

Raw material suppliers — providing essential biochemicals

Technology providers — developing transmembrane protein technologies

OEMs / manufacturers — producing transmembrane protein-based products

System integrators / EPCs — integrating transmembrane proteins into systems

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance services

Regulators/standards bodies — establishing guidelines and standards

In the Transmembrane Protein ecosystem, control points are primarily influenced by regulators and standards bodies, as their guidelines and approvals dictate the adoption and application of transmembrane proteins. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the production and distribution of products. Furthermore, switching costs, partnerships, and interoperability requirements can also affect the ecosystem's dynamics, with regional differences in regulations and standards potentially leading to variations in the ecosystem's structure and value flow.

Recent Industry Insights

The Transmembrane Protein industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships between major pharmaceutical companies and biotech firms have accelerated research and development in this field. Recently, there have been several mergers & acquisitions, allowing companies to expand their portfolios and strengthen their positions in the market. Additionally, innovative product/technology launches have improved the targeting and efficacy of transmembrane protein-based therapies. Regulatory bodies have also introduced regulatory changes to streamline the approval process for these therapies, driving growth in the industry. Furthermore, a shift in consumer or enterprise trends towards personalized medicine has fueled demand for transmembrane protein-based treatments. Several companies have also secured funding rounds or expansions to support their research and development efforts, underscoring the industry's potential for future growth.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Transmembrane Protein market outlook. The market exhibits high attractiveness due to its significant potential in drug discovery and development. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships. The long-term outlook is promising, driven by advancements in biotechnology and genomics. The innovation landscape is rapidly evolving, with emerging technologies such as CRISPR and gene editing. However, the demand-supply balance is a concern, with potential risks related to regulatory frameworks and intellectual property issues. Key risk factors include intense competition, high research and development costs, and uncertain regulatory environments.

11 items

1. Executive Summary

2. Transmembrane Protein Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Transmembrane Protein Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Transmembrane Protein Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cell Experiment

6.1.2. Immunoassay

6.1.3. CAR Positive Test

6.2. Global Transmembrane Protein Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Tetraspanin

6.2.2. Pentaspanin

6.2.3. Seven Transmembrane Proteins

6.2.4. Others

6.3. Global Transmembrane Protein Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Transmembrane Protein Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Transmembrane Protein Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Transmembrane Protein Market Competition by Key Manufacturers

8.1. Global Transmembrane Protein Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Transmembrane Protein: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. ACROBiosystems

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dima Biotech

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abiocenter

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sino Biological

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Detai Bioengineering

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Kactus Biosystems

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cusabio

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Transmembrane Protein Market

Figure 4: Global Transmembrane Protein Market: Drivers

Figure 5: Global Transmembrane Protein Market: Challenges

Figure 6: Global Transmembrane Protein Market: Trends

Figure 7: Global Transmembrane Protein Market: Opportunity

Figure 8: Global Transmembrane Protein Market: Restraint

Figure 9: Global Transmembrane Protein Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Transmembrane Protein Market Value (USD Million) By Region

Figure 15: Global Transmembrane Protein Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Transmembrane Protein Market Value (USD Million) By Region

Figure 23: Global Transmembrane Protein Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Transmembrane Protein Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Transmembrane Protein Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Transmembrane Protein Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Transmembrane Protein Market Value (USD Million) By Region

Table 10: Global Transmembrane Protein Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Transmembrane Protein Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Transmembrane Protein Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Transmembrane Protein Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: ACROBiosystems Basic Information And Sales Area

Table 31: ACROBiosystems. Products Portfolio

Table 32: Dima Biotech Basic Information And Sales Area

Table 33: Dima Biotech. Products Portfolio

Table 34: Abiocenter Basic Information And Sales Area

Table 35: Abiocenter. Products Portfolio

Table 36: Sino Biological Basic Information And Sales Area

Table 37: Sino Biological. Products Portfolio

Table 38: Detai Bioengineering Basic Information And Sales Area

Table 39: Detai Bioengineering. Products Portfolio

Table 40: Kactus Biosystems Basic Information And Sales Area

Table 41: Kactus Biosystems. Products Portfolio

Table 42: Cusabio Basic Information And Sales Area

Table 43: Cusabio. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Transmembrane Protein Market Value (USD Million) By Region

Table 49: Global Transmembrane Protein Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Transmembrane Protein Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.50 billion
Revenue forecast in 2033	3.33 billion
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ACROBiosystems; Dima Biotech; Abiocenter; Sino Biological; Detai Bioengineering; Kactus Biosystems; Cusabio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options